Paclitaxel
Sold as Biolyse paclitaxel, Anzatax, Cipla-paclitaxel, Genexol, Sandoz paclitaxel, Loxat, Aspen paclitaxel, Litha paclitaxel, Paclitaxel viatris, Mylan paclitaxel, Paclitaxel fresenius, Paclitaxel, Plixel, Paclitaxel eurolab, Accord-paclitaxel, Nanogix, Indaxol, Xaclitel, Paclitaxel AURO, Atilcap, Ebetaxel, Paclitaxel pch
No structure available
This product's active ingredient could not be matched to a single known compound.
Background
Registration
- Applicants
- 19
- Registrations
- 60
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Key Oncologics (Pty) LtdCancelled | Biolyse paclitaxel | for injection | 360024 | S4 | None |
| Pfizer Laboratories (Pty) LtdCancelled | Anzatax | Not stated | 360255 | S4 | None |
| Cipla Medpro (Pty) Ltd1 of 3 cancelled | Cipla-paclitaxel | 30 mg/5 ml, 100 mg/16,7 ml, 300 mg/50 ml | 410423, 410424, 410425 | S4 | None |
| Pharmacorp (Pty) Ltd | Genexol | 30 mg, 100 mg, 300 mg | 410915, 410924, 430246 | S4 | None |
| Sandoz South Africa (Pty) LtdCancelled | Sandoz paclitaxel | 30, 100, 300 | 411092, 411093, 411094 | S4 | None |
| Oethmaan Biosims (Pty) Ltd | Loxat | 30,0 mg/10,0 mg/300,0 mg | 411095, 411096, 411097 | S4 | PIPIL |
| Pharmacare limited û woodmeadCancelled | Aspen paclitaxel | 30 mg, 100 mg/16,67 ml, 260 mg, 300 mg | 420146, 420147, 420148, 420149 | S4 | None |
| Acino Pharma (Pty) Ltd | Litha paclitaxel | 30, 100, 150, 300 | 420624, 420625, 420626, 420627 | S4 | None |
| Viatris South Africa (Pty) Ltd | Paclitaxel viatris, Mylan paclitaxel | 30, 100, 300 | 420657, 420658, 420659 | S4 | PIPIL |
| Fresenius Kabi South Africa (Pty) Ltd | Paclitaxel fresenius, Paclitaxel | 30 mg/5 ml, 100 mg/16,7 ml, 300 mg/50 ml | 430237, 430239, 430244 | S4 | None |
| Safeline Pharmaceuticals (Pty) LtdCancelled | Plixel | 100 mg, 300 mg | 430467, 450613, 450614 | S4 | None |
| Eurolab (Pty) Ltd | Paclitaxel eurolab | 30, 100, 300 | 440374, 440375, 440376 | S4 | None |
| Accord Healthcare (Pty) Ltd | Accord-paclitaxel | 30mg/100mg/300mg | 440377, 440378, 440379 | S4 | PIPIL |
| Ranbaxy Pharmaceuticals (Pty) Ltd | Nanogix | 100, 300 | 540454, 540455 | S4 | None |
| Mc Pharma (Pty) LtdCertificate held by Ruby Pharmaceuticals (Pty) Ltd | Indaxol | 30 mg/ 100 mg/ 300 mg | 550437, 550438, 550439 | S4 | PIPIL |
| Aurogen South Africa (Pty) Ltd | Xaclitel, Paclitaxel AURO, Paclitaxel | 30 mg/ 5 ml, 30 mg/5 ml, 100 mg/ 16,7 ml, 100 mg/16,7 ml, 150 mg/ 25 ml, 150 mg/25 ml, 300 mg/ 50 ml, 300 mg/50 ml | 570201, 570202, 570203, 570204, 570205.201, 570206.202, 570207.203, 570208.204 | S4 | None |
| Hetero Drugs South Africa (Pty) Ltd | Atilcap | 30 mg/5 ml, 100 mg/16,7 ml, 300 mg/50 ml | 590318, 590319, 590320 | S4 | None |
| Adcock Ingram Critical Care (Pty) LtdCancelled | Ebetaxel | 30 mg, 100 mg, 150 mg, 300 mg | A400544, A400545, A400546, A400547 | S4 | None |
| Teva Pharmaceuticals (Pty) Ltd | Paclitaxel pch | 30, 100, 300 | A400609, A400610, A400611 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Biolyse paclitaxel for injection EACH 1,0 ml SOLUTION CONTAINS PACLITAXEL 6,0 mg | For injection | 36002436/26/0024 | Cancelled | S4 | None |
| Anzatax EACH 1,0 ml SOLUTION CONTAINS PACLITAXEL 6,0 mg | Not listed | 36025536/26/0255 | Cancelled | S4 | None |
| Cipla-paclitaxel 30 mg/5 ML EACH 5,0 ml VIAL CONTAINS PACLITAXEL 30,0 mg | 30 mg/5 ml | 41042341/26/0423 | Registered | S4 | None |
| Cipla-paclitaxel 100 mg/16,7 ML EACH 20,0 ml VIAL CONTAINS PACLITAXEL 100,0 mg | 100 mg/16,7 ml | 41042441/26/0424 | Registered | S4 | None |
| Cipla-paclitaxel 300 mg/50 ML EACH 50,0 ml VIAL CONTAINS: PACLITAXEL 300,0 mg | 300 mg/50 ml | 41042541/26/0425 | Cancelled | S4 | None |
| Genexol 100 MG EACH 5,0 ml VIAL CONTAINS PACLITAXEL 100,0 mg | 100 mg | 41091541/26/0915 | Registered | S4 | None |
| Genexol 30 MG EACH 5,0 ml VIAL CONTAINS PACLITAXEL 30,0 mg | 30 mg | 41092441/26/0924 | Registered | S4 | None |
| Sandoz paclitaxel 30 EACH 5,0 ml VIAL CONTAINS PACLITAXEL 30,0 mg | 30 | 41109241/26/1092 | Cancelled | S4 | None |
| Sandoz paclitaxel 100 EACH 5,0 ml VIAL CONTAINS PACLITAXEL 100,0 mg | 100 | 41109341/26/1093 | Cancelled | S4 | None |
| Sandoz paclitaxel 300 EACH 5,0 ml VIAL CONTAINS PACLITAXEL 300,0 mg | 300 | 41109441/26/1094 | Cancelled | S4 | None |
| Loxat 30 EACH 5,0 ml VIAL CONTAINS PACLITAXEL 30,0 mg | 30,0 mg/10,0 mg/300,0 mgConcentrate solution for infusion | 41109541/26/1095Approved 26 November 2024 | Registered | S4 | PIPIL |
| Loxat 100 EACH 5,0 ml VIAL CONTAINS PACLITAXEL 100,0 mg | 30,0 mg/10,0 mg/300,0 mgConcentrate solution for infusion | 41109641/26/1096Approved 26 November 2024 | Registered | S4 | PIPIL |
| Loxat 300 EACH 5,0 ml VIAL CONTAINS PACLITAXEL 300,0 mg | 30,0 mg/10,0 mg/300,0 mgConcentrate solution for infusion | 41109741/26/1097Approved 26 November 2024 | Registered | S4 | PIPIL |
| Aspen paclitaxel 30 MG EACH 5,0 ml SOLUTION CONTAINS PACLITAXEL 30,0 mg | 30 mg | 42014642/26/0146 | Cancelled | S4 | None |
| Aspen paclitaxel 100 mg/16,67 ML EACH 16,7 ml SOLUTION CONTAINS PACLITAXEL 100,0 mg | 100 mg/16,67 ml | 42014742/26/0147 | Cancelled | S4 | None |
| Aspen paclitaxel 260 MG EACH 43,33 ml SOLUTION CONTAINS PACLITAXEL 260,0 mg | 260 mg | 42014842/26/0148 | Cancelled | S4 | None |
| Aspen paclitaxel 300 MG EACH 50,0 ml SOLUTION CONTAINS PACLITAXEL 300,0 mg | 300 mg | 42014942/26/0149 | Cancelled | S4 | None |
| Litha paclitaxel 30 EACH VIAL CONTAINS PACLITAXEL 30,0 mg | 30 | 42062442/26/0624 | Registered | S4 | None |
| Litha paclitaxel 100 EACH VIAL CONTAINS PACLITAXEL 100,0 mg | 100 | 42062542/26/0625 | Registered | S4 | None |
| Litha paclitaxel 150 EACH VIAL CONTAINS PACLITAXEL 150,0 mg | 150 | 42062642/26/0626 | Registered | S4 | None |
| Litha paclitaxel 300 EACH VIAL CONTAINS PACLITAXEL 300,0 mg | 300 | 42062742/26/0627 | Registered | S4 | None |
| Paclitaxel 30 viatris EACH VIAL CONTAINS PACLITAXEL 30,0 mg | 30Concentrate for dilution for infusion. | 42065742/26/0657Approved 27 April 2024 | Registered | S4 | PIPIL |
| Paclitaxel 100 viatris EACH VIAL CONTAINS PACLITAXEL 100,0 mg | 100Concentrate for dilution for infusion. | 42065842/26/0658Approved 27 April 2024 | Registered | S4 | PIPIL |
| Mylan paclitaxel 300 EACH VIAL CONTAINS PACLITAXEL 300,0 mg | 300 | 42065942/26/0659 | Registered | S4 | None |
| Paclitaxel 30 mg/5 ML fresenius EACH 1,0 ml SOLUTION CONTAINS PACLITAXEL 6,0 mg | 30 mg/5 ml | 43023743/26/0237 | Registered | S4 | None |
| Paclitaxel 300 mg/50 ML fresenius EACH 1,0 ml SOLUTION CONTAINS PACLITAXEL 6,0 mg | 300 mg/50 ml | 43023943/26/0239 | Registered | S4 | None |
| Paclitaxel 100 mg/16,7 ML EACH 1,0 ml SOLUTION CONTAINS PACLITAXEL 6,0 mg | 100 mg/16,7 ml | 43024443/26/0244 | Registered | S4 | None |
| Genexol 300 MG EACH 50,0 ml VIAL CONTAINS PACLITAXEL 300,0 mg | 300 mg | 43024643/26/0246 | Registered | S4 | None |
| Plixel EACH 1,0 ml SOLUTION CONTAINS PACLITAXEL 6,0 mg | Not listed | 43046743/26/0467 | Cancelled | S4 | None |
| Paclitaxel 30 eurolab EACH 5,0 ml VIAL CONTAINS PACLITAXEL 30,0 mg | 30 | 44037444/26/0374 | Registered | S4 | None |
| Paclitaxel 100 eurolab EACH 5,0 ml VIAL CONTAINS PACLITAXEL 100,0 mg | 100 | 44037544/26/0375 | Registered | S4 | None |
| Paclitaxel 300 eurolab EACH 5,0 ml VIAL CONTAINS PACLITAXEL 300,0 mg | 300 | 44037644/26/0376 | Registered | S4 | None |
| Accord-paclitaxel 30 EACH 5,0 ml VIAL CONTAINS :PACLITAXEL 30,0 mg | 30mg/100mg/300mgConcentrate for solution for infusion | 44037744/26/0377Approved 3 October 2023 | Registered | S4 | PIPIL |
| Accord-paclitaxel 100 EACH 5,0 ml VIAL CONTAINS :PACLITAXEL 100,0 mg | 30mg/100mg/300mgConcentrate for solution for infusion | 44037844/26/0378Approved 3 October 2023 | Registered | S4 | PIPIL |
| Accord-paclitaxel 300 EACH 5,0 ml VIAL CONTAINS PACLITAXEL 300,0 mg | 30mg/100mg/300mgConcentrate for solution for infusion | 44037944/26/0379Approved 3 October 2023 | Registered | S4 | PIPIL |
| Plixel 100 MG EACH VIAL CONTAINS PACLITAXEL 100,0 mg | 100 mg | 45061345/26/0613 | Cancelled | S4 | None |
| Plixel 300 MG EACH VIAL CONTAINS PACLITAXEL 300,0 mg | 300 mg | 45061445/26/0614 | Cancelled | S4 | None |
| Nanogix 100 EACH VIAL CONTAINS PACLITAXEL 100,0 mg | 100 | 54045454/26/0454 | Registered | S4 | None |
| Nanogix 300 EACH VIAL CONTAINS PACLITAXEL 300,0 mg | 300 | 54045554/26/0455 | Registered | S4 | None |
| Indaxol 30 EACH 5,0 ml SOLUTION CONTAINS: PACLITAXEL 30,0 mg | 30 mg/ 100 mg/ 300 mgConcentrate for solution for infusion | 55043755/26/0437Approved 3 August 2022 | Registered | S4 | PIPIL |
| Indaxol 100 EACH 16,7 ml SOLUTION CONTAINS: PACLITAXEL 100,0 mg | 30 mg/ 100 mg/ 300 mgConcentrate for solution for infusion | 55043855/26/0438Approved 3 August 2022 | Registered | S4 | PIPIL |
| Indaxol 300 EACH 50,0 ml SOLUTION CONTAINS: PACLITAXEL 300,0 mg | 30 mg/ 100 mg/ 300 mgConcentrate for solution for infusion | 55043955/26/0439Approved 3 August 2022 | Registered | S4 | PIPIL |
| Xaclitel 30 mg/ 5 ML Each Vial contains: Paclitaxel 30,0 mg | 30 mg/ 5 ml | 57020157/26/0201 | Registered | S4 | None |
| Xaclitel 100 mg/ 16,7 ML Each Vial contains: Paclitaxel 100,0 mg | 100 mg/ 16,7 ml | 57020257/26/202 | Registered | S4 | None |
| Xaclitel 150 mg/ 25 ML Each Vial contains: Paclitaxel 150,0 mg | 150 mg/ 25 ml | 57020357/26/0203 | Registered | S4 | None |
| Xaclitel 300 mg/ 50 ML Each Vial contains: Paclitaxel 300,0 mg | 300 mg/ 50 ml | 57020457/26/0204 | Registered | S4 | None |
| Paclitaxel 30 mg/5 ML AURO Each Vial contains: Paclitaxel 30,0 mg | 30 mg/5 ml | 570205.20157/26/0205.201 | Registered | S4 | None |
| Paclitaxel 100 mg/16,7 ML Each Vial contains: Paclitaxel 100,0 mg | 100 mg/16,7 ml | 570206.20257/26/0206.202 | Registered | S4 | None |
| Paclitaxel 150 mg/25 ML Each Vial contains: Paclitaxel 150,0 mg | 150 mg/25 ml | 570207.20357/26/0207.203 | Registered | S4 | None |
| Paclitaxel 300 mg/50 ML Each Vial contains: Paclitaxel 300,0 mg | 300 mg/50 ml | 570208.20457/26/0208.204 | Registered | S4 | None |
| Atilcap 30 mg/5 ML EACH 5,0 ml SOLUTION CONTAINS: PACLITAXEL 30,0 mg | 30 mg/5 ml | 59031859/26/0318 | Registered | S4 | None |
| Atilcap 100 mg/16,7 ML EACH 16,7 ml SOLUTION CONTAINS: PACLITAXEL 100,0 mg | 100 mg/16,7 ml | 59031959/26/0319 | Registered | S4 | None |
| Atilcap 300 mg/50 ML EACH 50,0 ml SOLUTION CONTAINS: PACLITAXEL 300,0 mg | 300 mg/50 ml | 59032059/26/0320 | Registered | S4 | None |
| Ebetaxel 30 MG EACH 5,0 ml SUSPENSION CONTAINS PACLITAXEL 30,0 mg | 30 mg | A400544A40/26/0544 | Cancelled | S4 | None |
| Ebetaxel 100 MG EACH16,6 ml SUSPENSION CONTAINS PACLITAXEL 100,0 mg | 100 mg | A400545A40/26/0545 | Cancelled | S4 | None |
| Ebetaxel 150 MG EACH 25,0 ml SUSPENSION CONTAINS PACLITAXEL 150,0 mg | 150 mg | A400546A40/26/0546 | Cancelled | S4 | None |
| Ebetaxel 300 MG EACH 50,0 ml SUSPENSION CONTAINS PACLITAXEL 300,0 mg | 300 mg | A400547A40/26/0547 | Cancelled | S4 | None |
| Paclitaxel 30 pch EACH 1,0 ml SOLUTION CONTAINS PACLITAXEL 6,0 mg | 30 | A400609A40/26/0609 | Registered | S4 | None |
| Paclitaxel 100 pch EACH 1,0 ml SOLUTION CONTAINS PACLITAXEL 6,0 mg | 100 | A400610A40/26/0610 | Registered | S4 | None |
| Paclitaxel 300 pch EACH 1,0 ml SOLUTION CONTAINS PACLITAXEL 6,0 mg | 300 | A400611A40/26/0611 | Registered | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Paclitaxel
S4: Paclitaxel
Consolidated Schedules 06 July 2026, line 7455
Pharmacological class: Cytostatic agents (class 26)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Loxat 30, Oethmaan Biosims (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.